Position in GRAL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,886,400
+$7,070,400 QoQ
Shares Held
230,000
-34.3% QoQ
Ownership
0.536%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Casdin Capital, LLC holds $342,736,102 across 8 Diagnostics & Research names. GRAL ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WGS |
GeneDx Holdings Corp.
|
3,007,164 | $193,120,072 | |
| 2 | ILMN |
Illumina, Inc.
|
530,000 | $65,327,800 | |
| 3 | GH |
Guardant Health, Inc.
|
315,000 | $29,096,550 | |
| 4 | QGEN |
Qiagen N.V.
|
360,000 | $14,414,400 | |
| 5 | GRAL |
GRAIL, Inc.
This page
|
230,000 | $11,886,400 | |
| 6 | PSNL |
Personalis, Inc.
|
1,600,000 | $10,192,000 | |
| 7 | DGX |
Quest Diagnostics Inc
|
50,000 | $9,799,000 | |
| 8 | VCYT |
Veracyte, Inc.
|
276,308 | $8,899,880 |
All Filings in GRAL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,886,400 | 230,000 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $4,816,000 | 350,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,229,584 | 79,999 | Shares | Sole | 2024-10-18 | |
| No filing history on record for this holder in this stock. | ||||||